Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker DBVT
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | MPM BioImpact LLC | 15.22M | 4.8% | SCHEDULE 13G/A ↗ |
| Nov 12, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Raymond Debbane | 24.72M | 7.9% | SCHEDULE 13G/A ↗ |
| Nov 12, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Ulys, L.L.C. | 1.62M | 0.5% | SCHEDULE 13G/A ↗ |
| Nov 12, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Avicenna Life Sci Master GP LLC | 1.62M | 0.5% | SCHEDULE 13G/A ↗ |
| Nov 12, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Avicenna Life Sci Master Fund LP | 1.62M | 0.5% | SCHEDULE 13G/A ↗ |
| Nov 12, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Siren, L.L.C. | 23.10M | 7.3% | SCHEDULE 13G/A ↗ |
| Nov 12, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Invus Global Management, LLC | 23.10M | 7.3% | SCHEDULE 13G/A ↗ |
| Nov 12, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Invus Public Equities Advisors, LLC | 23.10M | 7.3% | SCHEDULE 13G/A ↗ |
| Nov 12, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Invus Public Equities, L.P. | 23.10M | 7.3% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | MPM BioImpact LLC | 18.33M | 6.2% | SCHEDULE 13G/A ↗ |
| Aug 6, 2026 | SCHEDULE 13G | DBVT DBV Technologies S.A. | RA Capital Healthcare Fund, L.P. | 18.29M | 5.8% | SCHEDULE 13G ↗ |
| Aug 6, 2026 | SCHEDULE 13G | DBVT DBV Technologies S.A. | Rajeev Shah | 18.29M | 5.8% | SCHEDULE 13G ↗ |
| Aug 6, 2026 | SCHEDULE 13G | DBVT DBV Technologies S.A. | Peter Kolchinsky | 18.29M | 5.8% | SCHEDULE 13G ↗ |
| Aug 6, 2026 | SCHEDULE 13G | DBVT DBV Technologies S.A. | RA Capital Management, L.P. | 18.29M | 5.8% | SCHEDULE 13G ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | MPM BioImpact LLC | 26.07M | 8.8% | SCHEDULE 13G/A ↗ |
| May 13, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Artisan Partners Limited Partnership | 2.22M | 3.7% | SCHEDULE 13G/A ↗ |
| May 13, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Artisan Investments GP LLC | 2.22M | 3.7% | SCHEDULE 13G/A ↗ |
| May 13, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Artisan Partners Holdings LP | 2.22M | 3.7% | SCHEDULE 13G/A ↗ |
| May 13, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Artisan Partners Asset Management Inc. | 2.22M | 3.7% | SCHEDULE 13G/A ↗ |
| May 13, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Phillip Gross | 22.27M | 7.3% | SCHEDULE 13G/A ↗ |
| May 13, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Robert Atchinson | 22.27M | 7.3% | SCHEDULE 13G/A ↗ |
| May 13, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Adage Capital Management, L.P. | 22.27M | 7.3% | SCHEDULE 13G/A ↗ |
| May 12, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Vivo Opportunity Cayman, LLC | 1.52M | 0.5% | SCHEDULE 13G/A ↗ |
| May 12, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Vivo Opportunity Cayman Fund, L.P. | 1.52M | 0.5% | SCHEDULE 13G/A ↗ |
| May 12, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Vivo Opportunity, LLC | 11.82M | 4.0% | SCHEDULE 13G/A ↗ |
| May 12, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Vivo Opportunity Fund Holdings, L.P. | 11.82M | 4.0% | SCHEDULE 13G/A ↗ |
| May 5, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Raymond Debbane | 19.31M | 6.5% | SCHEDULE 13G/A ↗ |
| May 5, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Ulys, L.L.C. | 1.31M | 0.4% | SCHEDULE 13G/A ↗ |
| May 5, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Avicenna Life Sci Master GP LLC | 1.31M | 0.4% | SCHEDULE 13G/A ↗ |
| May 5, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Avicenna Life Sci Master Fund LP | 1.31M | 0.4% | SCHEDULE 13G/A ↗ |
| May 5, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Siren, L.L.C. | 18.00M | 6.1% | SCHEDULE 13G/A ↗ |
| May 5, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Invus Global Management, LLC | 18.00M | 6.1% | SCHEDULE 13G/A ↗ |
| May 5, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Invus Public Equities Advisors, LLC | 18.00M | 6.1% | SCHEDULE 13G/A ↗ |
| May 5, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Invus Public Equities, L.P. | 18.00M | 6.1% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G | DBVT DBV Technologies S.A. | MPM BioImpact LLC | 24.58M | 9.9% | SCHEDULE 13G ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Bong Y. Koh | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Nimish Shah | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | VHCP Management EG, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | VHCP Management III, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Venrock Healthcare Capital Partners EG, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | VHCP Co-Investment Holdings III, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Venrock Healthcare Capital Partners III, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | VHCP Management II, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | VHCP Co-Investment Holdings II, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Venrock Healthcare Capital Partners II, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Kenneth Griffin | 8.15M | 3.5% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Citadel Securities GP LLC | 732,551 | 0.3% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Citadel Securities Group LP | 732,551 | 0.3% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Citadel Securities LLC | 47,240 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DBVT DBV Technologies S.A. | Citadel GP LLC | 7.41M | 3.1% | SCHEDULE 13G/A ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:26 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances